Zlotogora Joël, Grotto Itamar, Kaliner Ehud, Gamzu Ronni
Department of Community Genetics.
Public Health Services.
Genet Med. 2016 Feb;18(2):203-6. doi: 10.1038/gim.2015.55. Epub 2015 Apr 16.
The Israeli population genetic screening program for reproductive purposes, launched in January 2013, includes all known, nationally frequent severe diseases (carrier frequency 1:60 and/or disease frequency 1 in 15,000 live births). The carrier screening program is free of charge and offers testing for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy for nearly the entire population, according to disease frequency among the different groups within the population. We report the results of the first year of the program.
Data on the tests performed over a 12-month period were collected from laboratories nationwide.
More than 62,000 individuals were examined. The carrier frequency was within the expected range for most of the diseases. The few exceptions included lower carrier rates for cystic fibrosis among Muslim Arabs (1:236) and Druze (1:1,021) and Niemann-Pick type A among Muslim Arabs in a delineated region of Israel (1:229).
The national population genetic carrier screening is aimed toward providing couples with knowledge of the existing options for the prevention of serious genetic conditions when it is relevant for them. It is still too early to determine whether this aim has been achieved.
以色列于2013年1月启动的生殖目的人群基因筛查项目,涵盖了所有已知的、在全国范围内常见的严重疾病(携带频率为1:60及/或疾病频率为每15000例活产中有1例)。根据人群中不同群体的疾病频率,携带者筛查项目免费为几乎全体人群提供囊性纤维化、脆性X综合征和脊髓性肌萎缩症检测。我们报告该项目第一年的结果。
从全国各实验室收集了1年内所做检测的数据。
超过62000人接受了检查。大多数疾病的携带频率在预期范围内。少数例外情况包括,在穆斯林阿拉伯人(1:236)和德鲁兹人(1:1021)中,囊性纤维化的携带率较低;在以色列一个划定区域的穆斯林阿拉伯人中,尼曼-匹克病A型的携带率为1:229。
全国人群基因携带者筛查旨在为夫妇提供与他们相关的预防严重遗传疾病现有选择的知识。现在判断这一目标是否实现还为时过早。